Anand Buch, who serves as Chief Strategy Officer at Crexendo, Inc. (NASDAQ:CXDO), reported the sale of 88,000 shares of the company's common stock in multiple transactions executed on March 11 and March 13, 2026, according to a Form 4 submission to the Securities and Exchange Commission.
The aggregated proceeds from these sales amounted to $579,200, with transaction prices ranging from $6.35 to $6.735 per share. On March 11 specifically, Buch sold 40,000 shares as part of the activity disclosed in the filing. Following the reported trades, Buch's direct holdings in Crexendo stand at 447,498 shares.
These insider transactions come amid recent corporate developments for Crexendo. In its fourth-quarter 2025 report the company posted earnings per share of $0.09, narrowly exceeding the forecasted $0.08. At the same time, Crexendo's revenue for the quarter was reported at $18.1 million, a slight miss relative to the projected $18.14 million.
Separately, Crexendo announced the acquisition of ESI. Needham responded to the deal by reiterating a Buy rating on Crexendo and maintaining a $9.00 price target. The brokerage also adjusted its 2026 estimates to reflect the anticipated impact of the acquisition, according to the information released alongside the company's results.
Together, the insider selling, the mixed quarterly results and the ESI acquisition have drawn attention from market participants. The combination of a modest EPS beat, a marginal revenue shortfall and updated analyst forecasts tied to the acquisition has produced a mix of optimism and caution among investors closely watching Crexendo's execution and near-term outlook.
Context and implications
While the Form 4 filing provides clear detail on the scope and timing of Buch's stock sales, it does not include any statement from the insider explaining the transactions. The company financials and the strategic move to acquire ESI were disclosed separately, and Needham's maintained Buy rating and updated modeling reflect an analyst view that incorporates the acquisition's expected effects on 2026 results.